iRay Technology Hits Day Low at CNY 95.81 Amid Price Pressure

iRay Technology Co., Ltd. experienced a significant decline today, with the stock dropping by 8.01% to reach an intraday low of CNY 95.81. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by only 2.06% during the same period. Over the past week, iRay Technology has seen a more pronounced downturn, with a 12.4% decrease, and a 13.52% drop over the past month. Despite these recent challenges, the company has shown resilience over the past year, boasting a return of 53.0%, significantly outperforming the China Shanghai Composite's 11.5% gain. Financial metrics reveal that iRay Technology has faced difficulties, with negative results reported for the last three consecutive quarters. The company's net sales have grown at an annual rate of 23.97% over the past five years, but operating profit growth has lagged at 20.51%. Additionally, the rising raw material costs, which increased by 102.8% year-over-year, may be impacting profitability. With a market capitalization of CNY 34,948 million, iRay Technology operates within the Pharmaceuticals & Biotechnology sector, and its current price-to-book ratio stands at 4.69, indicating a relatively high valuation compared to its earnings.